The need for rules and regulations
Source abstract
Abstract
Nanotechnology could have an enormous impact on medicine but, says Michael Helmus, the regulations that govern new drugs and medical devices need to be updated before nanomedicine can be commercialized.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Fullerene Chemistry and Applications · Anesthesia and Neurotoxicity Research · Neuroethics, Human Enhancement, Biomedical Innovations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. www.fda.gov/nanotechnology
2. www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=208
3. www.emea.europa.eu/pdfs/human/genetherapy/7976906en.pdf
4. www.fda.gov/nanotechnology/ChBSA-nanotech-presentation06-04.ppt
5. Isakovic, I. et al. Toxicol. Sci. 91, 173–183 (2006).10.1093/toxsci/kfj127 ↗
6. www.acrymed.com
7. www.spirecorp.com/spire-biomedical/surface-treatment/spi-argent/index.php
8. www.angstrommedica.com/images/NanOss%20Clearance.htm
9. Brand, K. G. & Brand, I. Plast. Reconstr. Surg. 66, 591–955 (1980).10.1097/00006534-198010000-00015 ↗
10. www.nanotechproject.org/82/10506-regulating-the-products-of-nanotechnology